Gabapentin USP Powder API For Customer Compounding

Premium Gabapentin USP Powder API – Pharmaceutical Grade For Compounding Pharmacies, Hospitals, and Veterinary Clinics

Medisca’s Gabapentin USP Powder API provides compounding pharmacists, hospital pharmacies, and specialty medical providers with the highest quality active pharmaceutical ingredient (API) for custom medication solutions. Manufactured to strict USP standards for purity and potency, this bulk Gabapentin powder is trusted for compounding personalized treatments, ensuring safe and effective nerve pain, epilepsy, and neuropathic pain management for patients of all ages.

Key Features & Clinical Benefits

• High-Purity Gabapentin USP API (Powder Form) Ideal for creating custom dosage forms, including capsules, oral suspensions, liquids, topical gels, transdermal creams, and chewables for pediatrics, geriatrics, or veterinary use.

• Precision Custom Compounding Addresses diverse patient needs such as neuropathic pain, epilepsy, restless legs syndrome (RLS), and fibromyalgia with accurate, patient-specific strengths not available in commercial medications.

• Allergy-Friendly Compounding Enables the preparation of lactose-free, dye-free, preservative-free, and gluten-free Gabapentin medications, perfect for patients with sensitivities.

• Hospital & Clinic Trusted Relied on by hospital pharmacies, pain management clinics, neurological centers, and veterinary practitioners for chronic pain, nerve pain, and seizure control.

• Rigorous Quality Control Accompanied by Certificate of Analysis (COA), batch traceability, and full documentation for regulatory, clinical, and compounding pharmacy compliance.

Top Clinical Uses

• Neuropathic Pain Relief: Custom compounded Gabapentin for nerve pain, diabetic neuropathy, postherpetic neuralgia, and neuropathies.
• Epilepsy & Seizure Management: Oral and pediatric Gabapentin suspensions for adjunctive treatment of partial seizures.
• Fibromyalgia Treatment: Personalized compounded medications for chronic pain and fibromyalgia.
• Veterinary & Animal Compounding: Tailored Gabapentin solutions for chronic pain relief in dogs, cats, and exotic pets.
• Sensory Disorders & Anxiety: Formulated to assist in sensory processing disorder, anxiety, and RLS.
• Custom Dosage Adjustments: Ideal for pediatric, geriatric, and special needs patients requiring unique dosage forms.

Why Choose Medisca Gabapentin USP API?

• Pharmaceutical Grade, USP Verified – Guaranteed purity, consistency, and safety for all compounding applications.
• Flexible Bulk Supply – Cost-effective for pharmacies and hospitals with high custom prescription volume.
• Patient-Centric Customization – Supports allergy-friendly and dose-specific compounding.
• Clinically Trusted – Medisca is the preferred supplier of specialty compounding ingredients worldwide.

Buy Medisca Gabapentin USP Powder API today and give your pharmacy or clinic the power to create precise, custom compounded Gabapentin medications—trusted by healthcare leaders for nerve pain, epilepsy treatment, and superior patient outcomes.

Medisca—Setting the Gold Standard for Pharmaceutical Compounding Ingredients and Patient-Centered Custom Medication Solutions.

• Product: Gabapentin USP/EP Powder - Active Pharmaceutical Ingredient (API) in bulk powder form, manufactured by Medisca to United States Pharmacopeia and European Pharmacopoeia standards.
• Primary Use: For use by licensed compounding pharmacists, hospital pharmacies, and veterinary compounding operations to prepare custom patient-specific Gabapentin formulations not available as commercial finished products.
• Supported Dosage Forms: Capsules, oral suspensions, oral liquids, topical gels, transdermal creams, chewable formulations - compounded to patient-specific strength and excipient requirements.
• Allergy-Friendly Compounding: The pure API contains no gluten, lactose, dyes, or preservatives - compounded preparations can be formulated free of these components based on excipient selection by the pharmacist.
• Documentation Included: Certificate of Analysis (COA) and batch traceability records provided with every order, supporting USP <795>, USP <797>, and PCAB compliance documentation requirements.
• Manufacturer: Medisca - a globally recognised supplier of compounding ingredients and pharmaceutical-grade APIs with an established presence in North American compounding supply chains.
• Licensing Requirement: Purchase requires a valid pharmacy licence, medical licence, or equivalent professional credential. Not available for retail or consumer purchase.

• Neuropathic Pain Compounding: Intended to support pharmacists preparing patient-specific formulations for neuropathic pain conditions including diabetic neuropathy and postherpetic neuralgia, where commercial gabapentin strengths or excipient profiles are not appropriate for the patient.
• Epilepsy & Seizure Management: Intended to support preparation of oral suspensions and liquid formulations for paediatric patients requiring adjunctive partial seizure treatment at doses not achievable by splitting or crushing commercial tablets or capsules.
• Fibromyalgia & Chronic Pain: Intended to support compounding of patient-specific strengths for chronic pain and fibromyalgia patients who require dose titration or alternative delivery routes not available commercially.
• Restless Legs Syndrome (RLS) & Sensory Conditions: Intended to support formulation of personalised dosing for RLS and related sensory processing conditions where standard commercial dosing increments are clinically insufficient.
• Veterinary Compounding: Intended for use by licensed veterinary compounding pharmacies preparing gabapentin formulations for chronic pain management in dogs, cats, and exotic species - no commercially approved veterinary gabapentin product exists in the US, making compounded API the standard supply pathway.
• Paediatric & Geriatric Populations: The powder form enables preparation of low-dose, liquid, or chewable formulations for patients who cannot swallow capsules or who require sub-commercial dose increments for safe titration.
• Allergy-Sensitive Patients: Enables preparation of gabapentin formulations free of gluten, lactose, dyes, and preservatives for patients with documented sensitivities to excipients present in commercial gabapentin products.

• For Professional Use Only: This bulk Gabapentin USP powder API is not a finished pharmaceutical product and is not intended for direct patient administration. It must be compounded into a finished dosage form by a licensed pharmacist before patient use.
• Licensing Requirement: Purchase is restricted to buyers holding a valid pharmacy licence, medical licence, or equivalent professional credential as required by applicable state and federal regulations.
• State Scheduling Compliance: Gabapentin is not federally scheduled under the DEA Controlled Substances Act; however, it is scheduled at the state level in multiple US states including Tennessee, Kentucky, Michigan, and Virginia, among others. Purchasing pharmacies must verify and comply with current state-level scheduling and record-keeping requirements applicable to their jurisdiction.
• Handling Precautions: Handle bulk pharmaceutical powder with appropriate personal protective equipment (PPE) including gloves, eye protection, and respiratory protection where indicated. Refer to the Safety Data Sheet (SDS) provided with the product for full handling, storage, and disposal guidance.
• Storage Requirements: Store per conditions specified on the Certificate of Analysis and product labelling. Not specified in provided data for precise temperature or humidity parameters - refer to COA upon receipt.
• Compounding Compliance: All compounded preparations using this API must comply with USP <795> (non-sterile compounding) or USP <797> (sterile compounding) standards as applicable, along with applicable state pharmacy board regulations and PCAB accreditation standards where relevant.
• Not for Retail Sale: This product must not be resold or dispensed directly to patients or consumers. Retail or consumer purchase is not permitted.

• Licensing Requirement: A valid pharmacy licence, medical licence, DEA registration (where applicable), or equivalent professional credential is required to place an order. Mountainside Medical reserves the right to verify credentials before processing pharmaceutical API orders.
• Bulk & Wholesale Pricing: This product is available at wholesale pricing for licensed pharmacies, hospitals, and institutional buyers purchasing in volume. Gabapentin API price varies by quantity - contact the sales team directly for volume pricing: +1 (888) 687-4334 or sales@mountainside-medical.com.
• New Customer Discount: New customers receive 5% off their first purchase at Mountainside Medical - applicable to qualifying orders.
• Shipping: Free shipping on US orders over $100. Mountainside Medical ships US-wide. Orders are fulfilled from domestic inventory, avoiding international import delays and customs documentation burdens associated with sourcing directly from gabapentin powder manufacturers overseas.
• Order Support: For questions about pack sizes, availability, documentation requirements, or volume pricing, contact the Mountainside Medical sales team by phone at +1 (888) 687-4334 or by email at sales@mountainside-medical.com during business hours.
• Documentation Provided: Certificate of Analysis (COA) and batch traceability records are included with every order. Additional regulatory documentation requests can be directed to the sales team prior to purchase.

Gabapentin USP Powder API is a bulk active pharmaceutical ingredient intended exclusively for use by licensed compounding pharmacists, hospital pharmacies, veterinary compounding pharmacies, and authorised institutional buyers. This product is not a finished pharmaceutical product and must not be administered directly to patients without first being compounded into an appropriate dosage form by a licensed pharmacist in accordance with a valid prescription and applicable compounding regulations.

Purchase of this product requires a valid pharmacy licence, medical licence, or equivalent professional credential as mandated by applicable federal and state regulations. Mountainside Medical Equipment complies with all applicable federal and state requirements governing the sale and distribution of pharmaceutical APIs.

Gabapentin is not currently scheduled under the federal Controlled Substances Act; however, state-level scheduling applies in multiple US jurisdictions. It is the sole responsibility of the purchasing pharmacy or institution to verify and comply with all applicable state pharmacy board regulations, scheduling requirements, and record-keeping obligations in their jurisdiction prior to purchase and use.

Clinical claims referenced on this page reflect the intended pharmaceutical applications of Gabapentin USP as documented in the USP monograph and published pharmacological literature. These references do not constitute medical advice and do not imply FDA clearance for any specific compounded preparation. All compounded preparations must be produced in compliance with USP <795> and/or USP <797> standards and applicable state and federal compounding regulations.

Mountainside Medical Equipment makes no warranties, expressed or implied, regarding the suitability of any compounded preparation produced using this API for any specific patient or clinical indication. Prescribing, compounding, and dispensing decisions remain the professional responsibility of the licensed practitioners involved.

For regulatory, compliance, or clinical questions, consult your state pharmacy board, a licensed pharmacist, or a qualified clinical consultant.

• What is Gabapentin USP Powder API and how is it different from commercial gabapentin capsules?

  Gabapentin USP Powder API is the pure active pharmaceutical ingredient in bulk powder form — it is not a finished medication. Commercial gabapentin capsules or tablets are finished products manufactured to fixed strengths (typically 100mg, 300mg, 400mg) with fixed excipients. The bulk API is intended for licensed compounding pharmacists to formulate into patient-specific preparations — at custom strengths, in alternative dosage forms (liquids, gels, chewables), and with controlled excipient profiles. This makes it appropriate for patients who cannot use commercial gabapentin due to dosing limitations, swallowing difficulties, or excipient sensitivities.

• Is gabapentin gluten free?

  The pure Gabapentin USP powder API itself contains no gluten. Whether a finished compounded gabapentin preparation is gluten-free depends entirely on the excipients — fillers, carriers, flavouring agents — chosen by the compounding pharmacist. Because this product is a pure API, a pharmacist can formulate a genuinely gluten-free gabapentin preparation by selecting appropriate gluten-free excipients. The same logic applies to lactose-free, dye-free, and preservative-free formulations. This is one of the primary clinical advantages of compounding from a clean API versus dispensing commercial gabapentin products with fixed excipient formulas.

• What documentation is provided with each order?

  Each order includes a Certificate of Analysis (COA) and batch traceability documentation. The COA confirms that the specific batch meets USP monograph specifications for identity, purity, potency, and physical characteristics. Batch traceability records support USP 795 and 797 compliance, PCAB accreditation documentation, and state pharmacy board inspection requirements. If you require additional regulatory or quality documentation beyond the standard COA package, contact the Mountainside Medical sales team prior to placing your order: +1 (888) 687-4334 or sales@mountainside-medical.com.

• Do I need a licence to purchase Gabapentin USP Powder API?

  Yes. A valid pharmacy licence, medical licence, or equivalent professional credential is required to purchase pharmaceutical-grade gabapentin API through Mountainside Medical. This product is not available for retail or consumer purchase. Gabapentin is not federally scheduled under the DEA Controlled Substances Act, but it is scheduled at the state level in several US states. Purchasing pharmacies and institutions are responsible for verifying their state-level compliance obligations — including any scheduling, record-keeping, or dispensing requirements applicable in their jurisdiction — before ordering.

• Can this API be used for veterinary compounding?

  Yes. This Gabapentin USP Powder API is appropriate for use by licensed veterinary compounding pharmacies. There is no commercially approved gabapentin product for veterinary use in the United States, which means compounded gabapentin — prepared from pharmaceutical-grade bulk API — is the standard pathway for veterinarians managing chronic pain in dogs, cats, and exotic species under a valid veterinary prescription. The bulk powder form supports a range of veterinary dosage forms including oral liquids, flavoured chewables, and transdermal preparations suited to different species and patient compliance profiles.

• How does gabapentin API price compare between direct manufacturer sourcing and distributor purchasing?

  Gabapentin powder price from domestic distributors like Mountainside Medical reflects wholesale pricing with the added value of domestic inventory, import-compliant supply chain documentation, and consistent COA availability. Sourcing directly from overseas gabapentin powder manufacturers may offer a lower per-gram cost at very high volumes, but introduces customs documentation requirements, international shipping variables, and import compliance responsibilities that most compounding pharmacies are not operationally structured to manage. For the majority of domestic compounding operations, distributor-level pricing through an established wholesale supplier represents the more cost-effective and compliance-reliable option. Contact the sales team for current volume pricing: +1 (888) 687-4334.

• What compounded dosage forms can be prepared using this Gabapentin powder?

  Gabapentin USP powder is water-soluble and physically compatible with a wide range of compounding vehicles. Dosage forms commonly prepared from this API include hard-gelatin or vegetarian capsules at custom strengths, oral suspensions and liquids particularly for paediatric and geriatric patients, topical gels and creams for localised neuropathic pain where systemic exposure should be minimised, transdermal preparations, and chewable formulations commonly used in veterinary compounding. The appropriate dosage form for any given patient should be determined by the prescribing clinician and compounding pharmacist based on clinical indication, patient factors, and applicable compounding standards.